News/ News/ R&D Calliditas plans to file rare kidney disease drug Nefecon after phase 3 success Richard Staines Calliditas, IGaN, Nefecon, R&D, Rare diseases 0 Comment Swedish biotech Calliditas has announced plans to file its rare disease drug Nefecon with the FDA early next Share X Calliditas plans to file rare kidney disease drug Nefecon after phase 3 success https://pharmaphorum.com/news/calliditas-plans-to-file-rare-disease-drug-nefecon-after-phase-3-success/
